Considerations for the Design of a Systematic Review of Interventions for Preventing Clinical Alzheimer's-Type Dementia, Mild Cognitive Impairment, and Age-Related Cognitive Decline: Letter Report (2015)

Chapter: Enclosure A: Committee on Decreasing the Risk of Alzheimer's-Type Dementia, Mild Cognitive Impairment, and Age-Related Cognitive Impairment

Previous Chapter: Letter Report
Suggested Citation: "Enclosure A: Committee on Decreasing the Risk of Alzheimer's-Type Dementia, Mild Cognitive Impairment, and Age-Related Cognitive Impairment." National Academies of Sciences, Engineering, and Medicine. 2015. Considerations for the Design of a Systematic Review of Interventions for Preventing Clinical Alzheimer's-Type Dementia, Mild Cognitive Impairment, and Age-Related Cognitive Decline: Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/21885.

Enclosure A: Committee on Decreasing the Risk of Alzheimer’s-Type Dementia, Mild Cognitive Impairment, and Age-Related Cognitive Impairment

Alan I. Leshner (Chair), CEO Emeritus, American Association for the Advancement of Science

Marilyn Albert, Professor of Neurology, Director of the Division of Cognitive Neuroscience, Johns Hopkins University School of Medicine

Lisa L. Barnes, Professor of Neurological Sciences and Behavioral Sciences, Director of the Rush Center of Excellence on Disparities in HIV and Aging, Rush University Medical Center

Dan G. Blazer, J. P. Gibbons Professor of Psychiatry Emeritus, Duke University Medical Center

Mark A. Espeland, Professor of Biostatistical Sciences, Wake Forest School of Medicine

J. Taylor Harden, Executive Director of the National Hartford Centers of Gerontological Nursing Excellence, Gerontological Society of America

Claudia H. Kawas, Professor of Neurology, Professor of Neurobiology and Behavior, University of California, Irvine

Nan M. Laird, Harvey V. Fineberg Research Professor of Public Health, Harvard University

Story Landis, Director Emeritus, National Institute of Neurological Disorders and Stroke

Kenneth M. Langa, Cyrus Sturgis Professor of Medicine, University of Michigan and Veterans Affairs Ann Arbor Healthcare System

Eric B. Larson, Vice President for Research, Group Health Executive Director, Group Health Research Institute

José A. Luchsinger, Florence Irving Associate Professor of Medicine, Associate Professor of Epidemiology, Columbia University

Ronald C. Petersen, Director, Alzheimer’s Disease Research Center; Director, Mayo Clinic Study of Aging, Mayo Clinic

Ralph L. Sacco, Professor and Olemberg Chair of Neurology, Executive Director of the McKnight Brain Institute, University of Miami; Chief of Neurology, Jackson Memorial Hospital

Sudha Seshadri, Professor of Neurology, Boston University School of Medicine

Leslie B. Snyder, Professor of Communications, University of Connecticut

Kristine Yaffe, Professor of Psychiatry, Neurology, and Epidemiology and Biostatistics, Vice Chair for Clinical and Translational Research, Roy and Marie Scola Endowed Chair, University of California, San Francisco

Study Staff

Clare Stroud, Study Director

Adrienne Stith Butler, Senior Program Officer

Sheena Posey Norris, Associate Program Officer

Annalyn Welp, Senior Program Assistant

Hilary Bragg, Program Coordinator

Andrew M. Pope, Director, Board on Health Sciences Policy

Suggested Citation: "Enclosure A: Committee on Decreasing the Risk of Alzheimer's-Type Dementia, Mild Cognitive Impairment, and Age-Related Cognitive Impairment." National Academies of Sciences, Engineering, and Medicine. 2015. Considerations for the Design of a Systematic Review of Interventions for Preventing Clinical Alzheimer's-Type Dementia, Mild Cognitive Impairment, and Age-Related Cognitive Decline: Letter Report. Washington, DC: The National Academies Press. doi: 10.17226/21885.
Page 9
Next Chapter: Enclosure B: Statement of Task
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.